Jennifer Lynn Minai Azary Context Therapeutics Inc. (CNTX) insider trading activity

Jennifer Lynn Minai Azary is Chief Financial Officer of Context Therapeutics Inc.. Currently has a direct ownership of 80,010 shares of CNTX, which is worth approximately $45,605. The most recent transaction as insider was on Jun 06, 2025, when has been sold 40,010 shares (Common Stock) at a price of $0.64 per share, resulting in proceeds of $25,606. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 80K

100.02% 3M change

100.02% 12M change

Total Value Held $45,605

Jennifer Lynn Minai-Azary Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 06 2025	BUY Open market or private purchase	$25,606 $0.64 p/Share	40,010 Added 33.34%	80,010 Common Stock
Dec 16 2022	BUY Open market or private purchase	$18,500 $0.74 p/Share	25,000 Added 38.46%	40,000 Common Stock
Aug 17 2022	BUY Open market or private purchase	$27,000 $1.8 p/Share	15,000 Added 50.0%	15,000 Common Stock

Also insider at

TPST

Tempest Therapeutics, Inc. Healthcare

Chief Financial Officer

JLM